ArticleFish physiology and biochemistry2026
Establishment, characterization and myogenic capacity of a muscle-derived cell line from Korean rockfish (Sebastes schlegelii).
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A cell line from Korean rockfish, Sebastes schlegelii muscle was successfully established and characterized. Primary cultures were initiated by enzymatic digestion and maintained in Leibovitz-15 (L-15) medium supplemented with 20% fetal bovine serum (FBS). The cells were continuously sub-cultured and maintained in L-15 with 10% FBS, 10 ng/mL fibroblast growth factor-2 (bFGF), and 1% antibiotics (penicillin/streptomycin and antibiotic/antimycotic solution) for more than 60 passages over 10 months, and named Korean rockfish muscle Sebastes schlegelii-1 (KRMSS-1) cell line. Under experimental conditions, best growth was achieved at 24 °C with 20% FBS concentration and 10 ng/mL bFGF addition. Cryopreservation using 5% dimethyl sulfoxide (DMSO) resulted in an 85-90% recovery rate after three months of freezing. Amplification of a CO1 fragment of the expected size provided supporting evidence for the rockfish origin of the KRMSS-1 cell line. Myogenic capacity was checked following serum reduction to 2% horse serum, resulting in myocyte alignment and cell fusion. During progression of the differentiation process, myosin heavy chain (MyHC) immunofluorescence staining revealed positive fluorescence distributed along elongated and enlarged cytoplasmic regions, indicating myogenic capacity. Differentiation success was further confirmed by increased protein expression of myogenin, desmin, and MyHC. Activation of intracellular PI3K/Akt/mTor and MEK/ERK pathways suggest a potential association between pathway activation and the differentiation process. Lastly, an increased proportion of cells in the G0/G1 phase at day 3 post-induction confirmed cell-cycle withdrawal. Collectively, this study established a new teleost muscle cell line with myogenic potential, providing a new model for muscle cell physiology research and for future aquaculture biotechnology applications.
Indexed as
Identifiers
42525306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.